Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (The Framingham Heart Study)

Colleen Sam, Joseph M. Massaro, Ralph B. D'Agostino, Daniel Levy, Jarvis W. Lambert, Philip A. Wolf, Emelia J. Benjamin

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The Framingham Heart Study records of participants with atrial fibrillation (AF) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of warfarin and aspirin use in AF. Anticoagulant use increased significantly in the 393 men and women (mean ages 72.5 and 79.0 years, respectively) who developed AF over the observation period: aspirin use increased from 14% to 39% in men and from 19% to 33% in women, and warfarin use increased from 10% to 39% in men and from 17% to 38% in women. There were no significant gender differences in anticoagulant use (p = 0.61), but participants using warfarin were younger. A total of 65 participants (17%) had major bleeding complications ≤5 years after initial AF. Age was not a significant predictor of bleeding.

Original languageEnglish (US)
Pages (from-to)947-951
Number of pages5
JournalAmerican Journal of Cardiology
Volume94
Issue number7
DOIs
StatePublished - Oct 1 2004

Fingerprint

Warfarin
Atrial Fibrillation
Aspirin
Hemorrhage
Anticoagulants
Observation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (The Framingham Heart Study). / Sam, Colleen; Massaro, Joseph M.; D'Agostino, Ralph B.; Levy, Daniel; Lambert, Jarvis W.; Wolf, Philip A.; Benjamin, Emelia J.

In: American Journal of Cardiology, Vol. 94, No. 7, 01.10.2004, p. 947-951.

Research output: Contribution to journalArticle

Sam, Colleen ; Massaro, Joseph M. ; D'Agostino, Ralph B. ; Levy, Daniel ; Lambert, Jarvis W. ; Wolf, Philip A. ; Benjamin, Emelia J. / Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (The Framingham Heart Study). In: American Journal of Cardiology. 2004 ; Vol. 94, No. 7. pp. 947-951.
@article{76bc486593e948ba85c272ba94b78384,
title = "Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (The Framingham Heart Study)",
abstract = "The Framingham Heart Study records of participants with atrial fibrillation (AF) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of warfarin and aspirin use in AF. Anticoagulant use increased significantly in the 393 men and women (mean ages 72.5 and 79.0 years, respectively) who developed AF over the observation period: aspirin use increased from 14{\%} to 39{\%} in men and from 19{\%} to 33{\%} in women, and warfarin use increased from 10{\%} to 39{\%} in men and from 17{\%} to 38{\%} in women. There were no significant gender differences in anticoagulant use (p = 0.61), but participants using warfarin were younger. A total of 65 participants (17{\%}) had major bleeding complications ≤5 years after initial AF. Age was not a significant predictor of bleeding.",
author = "Colleen Sam and Massaro, {Joseph M.} and D'Agostino, {Ralph B.} and Daniel Levy and Lambert, {Jarvis W.} and Wolf, {Philip A.} and Benjamin, {Emelia J.}",
year = "2004",
month = "10",
day = "1",
doi = "10.1016/j.amjcard.2004.06.038",
language = "English (US)",
volume = "94",
pages = "947--951",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (The Framingham Heart Study)

AU - Sam, Colleen

AU - Massaro, Joseph M.

AU - D'Agostino, Ralph B.

AU - Levy, Daniel

AU - Lambert, Jarvis W.

AU - Wolf, Philip A.

AU - Benjamin, Emelia J.

PY - 2004/10/1

Y1 - 2004/10/1

N2 - The Framingham Heart Study records of participants with atrial fibrillation (AF) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of warfarin and aspirin use in AF. Anticoagulant use increased significantly in the 393 men and women (mean ages 72.5 and 79.0 years, respectively) who developed AF over the observation period: aspirin use increased from 14% to 39% in men and from 19% to 33% in women, and warfarin use increased from 10% to 39% in men and from 17% to 38% in women. There were no significant gender differences in anticoagulant use (p = 0.61), but participants using warfarin were younger. A total of 65 participants (17%) had major bleeding complications ≤5 years after initial AF. Age was not a significant predictor of bleeding.

AB - The Framingham Heart Study records of participants with atrial fibrillation (AF) during 1980 and 1994 were retrospectively reviewed to determine the prevalence of warfarin and aspirin use in AF. Anticoagulant use increased significantly in the 393 men and women (mean ages 72.5 and 79.0 years, respectively) who developed AF over the observation period: aspirin use increased from 14% to 39% in men and from 19% to 33% in women, and warfarin use increased from 10% to 39% in men and from 17% to 38% in women. There were no significant gender differences in anticoagulant use (p = 0.61), but participants using warfarin were younger. A total of 65 participants (17%) had major bleeding complications ≤5 years after initial AF. Age was not a significant predictor of bleeding.

UR - http://www.scopus.com/inward/record.url?scp=5344228251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5344228251&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2004.06.038

DO - 10.1016/j.amjcard.2004.06.038

M3 - Article

C2 - 15464686

AN - SCOPUS:5344228251

VL - 94

SP - 947

EP - 951

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 7

ER -